Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Boehringer Ingelheim
Colorcon
Express Scripts
Medtronic

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR CELECOXIB; TRAMADOL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Celecoxib; Tramadol Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00290901 ↗ Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain. Completed Pfizer Phase 4 2006-03-01 This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.
NCT00290901 ↗ Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain. Completed Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Phase 4 2006-03-01 This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.
NCT00348452 ↗ A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA) Completed Bausch Health Americas, Inc. Phase 3 2002-09-01 The purpose of this study is to compare the analgesic efficacy and safety of tramadol HCl ER 100 mg, 200 mg and 300 mg once a day (QD), with placebo in patients with moderate to severe pain due to OA. For the purposes of this study, celecoxib will serve as a positive control to validate the sensitivity of the model. The study hypothesis is that tramadol HCl ER is safe and effective in the treatment of moderate to severe pain due to OA.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Celecoxib; Tramadol Hydrochloride

Condition Name

Condition Name for Celecoxib; Tramadol Hydrochloride
Intervention Trials
Pain 3
Hysteroscopy 3
Osteoarthritis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Celecoxib; Tramadol Hydrochloride
Intervention Trials
Osteoarthritis 3
Pain, Postoperative 2
Chronic Pain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Celecoxib; Tramadol Hydrochloride

Trials by Country

Trials by Country for Celecoxib; Tramadol Hydrochloride
Location Trials
United States 52
Egypt 4
Canada 2
Korea, Republic of 2
Philippines 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Celecoxib; Tramadol Hydrochloride
Location Trials
California 4
Arizona 3
Texas 3
Maryland 3
Utah 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Celecoxib; Tramadol Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Celecoxib; Tramadol Hydrochloride
Clinical Trial Phase Trials
Phase 4 9
Phase 3 7
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Celecoxib; Tramadol Hydrochloride
Clinical Trial Phase Trials
Completed 13
Unknown status 6
Recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Celecoxib; Tramadol Hydrochloride

Sponsor Name

Sponsor Name for Celecoxib; Tramadol Hydrochloride
Sponsor Trials
Cairo University 5
Pfizer 2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Celecoxib; Tramadol Hydrochloride
Sponsor Trials
Other 18
Industry 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Medtronic
AstraZeneca
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.